2 reports of this reaction
2.3% of all LEVOTHYROXINE, LIOTHYRONINE reports
#14 most reported adverse reaction
PRODUCT ODOUR ABNORMAL is the #14 most commonly reported adverse reaction for LEVOTHYROXINE, LIOTHYRONINE, manufactured by Acella Pharmaceuticals, LLC. There are 2 FDA adverse event reports linking LEVOTHYROXINE, LIOTHYRONINE to PRODUCT ODOUR ABNORMAL. This represents approximately 2.3% of all 87 adverse event reports for this drug.
Patients taking LEVOTHYROXINE, LIOTHYRONINE who experience product odour abnormal should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PRODUCT ODOUR ABNORMAL is a less commonly reported adverse event for LEVOTHYROXINE, LIOTHYRONINE, but still significant enough to appear in the safety profile.
In addition to product odour abnormal, the following adverse reactions have been reported for LEVOTHYROXINE, LIOTHYRONINE:
The following drugs have also been linked to product odour abnormal in FDA adverse event reports:
PRODUCT ODOUR ABNORMAL has been reported as an adverse event in 2 FDA reports for LEVOTHYROXINE, LIOTHYRONINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PRODUCT ODOUR ABNORMAL accounts for approximately 2.3% of all adverse event reports for LEVOTHYROXINE, LIOTHYRONINE, making it a notable side effect.
If you experience product odour abnormal while taking LEVOTHYROXINE, LIOTHYRONINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.